Do beta-blockers and inhibitors of the renin-angiotensin aldosterone system improve outcomes in patients with heart failure and left ventricular ejection fraction >40%? (2019)
Attributed to:
'Unlocking therapeutic innovation in heart failure through genomic data science
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/heartjnl-2018-313855
PubMed Identifier: 31345952
Publication URI: http://europepmc.org/abstract/MED/31345952
Type: Journal Article/Review
Volume: 105
Parent Publication: Heart (British Cardiac Society)
Issue: 20
ISSN: 1355-6037